Click here for an archive of Cramer's "Mad Money" recaps.
Medical device makers' stocks should be rocking in this market, Jim Cramer said Wednesday on his "Mad Money" TV show. But, because a number have received Department of Justice subpoenas, Kyphon (KYPH) is the only one that has pricing power, said Cramer.The DOJ is investigating medical device companies for possible violation of federal anti-kickback rules. Those having received subpoenas include Zimmer Holdings (ZMH - Get Report), Stryker (SYK - Get Report), Biomet (BMET), Guidant (GDT), Medtronic (MDT - Get Report) and St. Jude Medical (STJ), said Cramer. That means those companies won't dare raise prices while the investigation is ongoing, he said. Although it's stock has done well, St. Jude's, said Cramer, is only up for ancillary reasons. Cramer would ring the register. Another stock in the group, Boston Scientific (BSX), is facing a class-action suit; Cramer wouldn't touch it. That leaves only Kyphon, a maker of medical devices for spinal ailments, said Cramer. Kyphon hasn't received a subpoena, and that means it has legitimate pricing power, he said.